These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
913 related items for PubMed ID: 18832579
1. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. Behmoaram E, Bijian K, Jie S, Xu Y, Darnel A, Bismar TA, Alaoui-Jamali MA. Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579 [Abstract] [Full Text] [Related]
2. The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence. Sun CK, Ng KT, Sun BS, Ho JW, Lee TK, Ng I, Poon RT, Lo CM, Liu CL, Man K, Fan ST. Br J Cancer; 2007 Jul 02; 97(1):50-7. PubMed ID: 17551499 [Abstract] [Full Text] [Related]
3. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, Lo CM, Poon RT, Fan ST. Carcinogenesis; 2008 Nov 02; 29(11):2096-105. PubMed ID: 18765415 [Abstract] [Full Text] [Related]
5. Wilms' tumor 1 protein and focal adhesion kinase mediate keratinocyte growth factor signaling in breast cancer cells. Zang XP, Pento JT, Tari AM. Anticancer Res; 2008 Nov 02; 28(1A):133-7. PubMed ID: 18383836 [Abstract] [Full Text] [Related]
6. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D. Cancer Res; 2006 Apr 01; 66(7):3903-11. PubMed ID: 16585219 [Abstract] [Full Text] [Related]
7. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. Benlimame N, He Q, Jie S, Xiao D, Xu YJ, Loignon M, Schlaepfer DD, Alaoui-Jamali MA. J Cell Biol; 2005 Nov 07; 171(3):505-16. PubMed ID: 16275754 [Abstract] [Full Text] [Related]
8. Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer. Zhang S, Qiu X, Gu Y, Wang E. Lung Cancer; 2008 Dec 07; 62(3):295-301. PubMed ID: 18571765 [Abstract] [Full Text] [Related]
9. Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase. Cai W, Ye L, Sun J, Mansel RE, Jiang WG. Int J Mol Med; 2010 Apr 07; 25(4):573-80. PubMed ID: 20198306 [Abstract] [Full Text] [Related]
10. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Fernandis AZ, Prasad A, Band H, Klösel R, Ganju RK. Oncogene; 2004 Jan 08; 23(1):157-67. PubMed ID: 14712221 [Abstract] [Full Text] [Related]
11. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Payne SL, Fogelgren B, Hess AR, Seftor EA, Wiley EL, Fong SF, Csiszar K, Hendrix MJ, Kirschmann DA. Cancer Res; 2005 Dec 15; 65(24):11429-36. PubMed ID: 16357151 [Abstract] [Full Text] [Related]
12. Expression of focal adhesion kinase (p125 FAK) and proline-rich tyrosine kinase 2 (PYK2/CAKb) in cerebral metastases, correlation with VEGF-R-, ecNOS III-labelling and morphometric data. Ludwig HC, Akhavan-Shigari R, Rausch S, Schallock K, Quentin C, Bockermann V, Kolenda H. Anticancer Res; 2000 Dec 15; 20(3A):1419-24. PubMed ID: 10928051 [Abstract] [Full Text] [Related]
13. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts. Schwock J, Dhani N, Cao MP, Zheng J, Clarkson R, Radulovich N, Navab R, Horn LC, Hedley DW. Cancer Res; 2009 Jun 01; 69(11):4750-9. PubMed ID: 19458065 [Abstract] [Full Text] [Related]
14. High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome. Schmitz KJ, Grabellus F, Callies R, Otterbach F, Wohlschlaeger J, Levkau B, Kimmig R, Schmid KW, Baba HA. Breast Cancer Res; 2005 Jun 01; 7(2):R194-203. PubMed ID: 15743500 [Abstract] [Full Text] [Related]
19. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, Simkins S, Xu L. Clin Cancer Res; 2000 Jun 01; 6(6):2417-23. PubMed ID: 10873094 [Abstract] [Full Text] [Related]
20. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Mitra SK, Lim ST, Chi A, Schlaepfer DD. Oncogene; 2006 Jul 27; 25(32):4429-40. PubMed ID: 16547501 [Abstract] [Full Text] [Related] Page: [Next] [New Search]